Global trial confirms benefit of antacids on bleeding prevention for ventilated patients

  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 45 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 38%
  • Publisher: 51%

Medicine Research News News

Medicine Research,Health Research News,Health Research

A widely available drug helps prevent upper gastrointestinal bleeding in critically ill adults on a breathing machine, according to the results of a global study and meta-analysis led by researchers at McMaster University.

Global trial confirms benefit of antacids on bleeding prevention for ventilated patients retrieved 14 June 2024 from https://medicalxpress.com/news/2024-06-global-trial-benefit-antacids-ventilated.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Osaka University to pioneer world-first clinical trial for refractory prostate cancer with alpha-ray therapyA research team at Osaka University will start an investigator-initiated clinical trial for refractory prostate cancer patients after the successful development of a new alpha-ray therapeutic agent ([At-211] PSMA-5) and confirmation of its efficacy in animal models.
Source: NewsMedical - 🏆 19. / 71 Read more »